# Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates

> **NCT01533558** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Invasive Fungal Infection

## Interventions

- **DRUG:** caspofungin

## Key facts

- **NCT ID:** NCT01533558
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533558, "Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01533558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*